Tsuji, M.; Maki, S.; Enomoto, N.; Okamoto, K.; Kitamura, A.; Magawa, S.; Takakura, S.; Nii, M.; Tanaka, K.; Yodoya, N.;
et al. Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction. Medicina 2023, 59, 900.
https://doi.org/10.3390/medicina59050900
AMA Style
Tsuji M, Maki S, Enomoto N, Okamoto K, Kitamura A, Magawa S, Takakura S, Nii M, Tanaka K, Yodoya N,
et al. Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction. Medicina. 2023; 59(5):900.
https://doi.org/10.3390/medicina59050900
Chicago/Turabian Style
Tsuji, Makoto, Shintaro Maki, Naosuke Enomoto, Kota Okamoto, Asa Kitamura, Shoichi Magawa, Sho Takakura, Masafumi Nii, Kayo Tanaka, Noriko Yodoya,
and et al. 2023. "Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction" Medicina 59, no. 5: 900.
https://doi.org/10.3390/medicina59050900
APA Style
Tsuji, M., Maki, S., Enomoto, N., Okamoto, K., Kitamura, A., Magawa, S., Takakura, S., Nii, M., Tanaka, K., Yodoya, N., Tanaka, H., Sawada, H., Kondo, E., Hirayama, M., & Ikeda, T.
(2023). Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction. Medicina, 59(5), 900.
https://doi.org/10.3390/medicina59050900
